EP2024422A1 - Composes hybrides a base de silicones et a base d'au moins une autre entite moleculaire, polymere ou non, notamment de type polyol(s), leur procede de preparation et leurs applications - Google Patents
Composes hybrides a base de silicones et a base d'au moins une autre entite moleculaire, polymere ou non, notamment de type polyol(s), leur procede de preparation et leurs applicationsInfo
- Publication number
- EP2024422A1 EP2024422A1 EP07729143A EP07729143A EP2024422A1 EP 2024422 A1 EP2024422 A1 EP 2024422A1 EP 07729143 A EP07729143 A EP 07729143A EP 07729143 A EP07729143 A EP 07729143A EP 2024422 A1 EP2024422 A1 EP 2024422A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- group
- sii
- functionalization
- siil
- entity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 77
- 229920000642 polymer Polymers 0.000 title claims abstract description 29
- 229920005862 polyol Polymers 0.000 title claims abstract description 24
- 229920001296 polysiloxane Polymers 0.000 title claims abstract description 20
- 150000003077 polyols Chemical class 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title claims description 21
- 238000002360 preparation method Methods 0.000 title description 16
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 37
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 34
- -1 saccharides) Chemical class 0.000 claims abstract description 33
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 19
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 13
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 13
- 239000011707 mineral Substances 0.000 claims abstract description 13
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 13
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 11
- 239000004952 Polyamide Substances 0.000 claims abstract description 10
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 10
- 229920002647 polyamide Polymers 0.000 claims abstract description 10
- 239000002537 cosmetic Substances 0.000 claims abstract description 9
- 229920001515 polyalkylene glycol Polymers 0.000 claims abstract description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 8
- 239000004793 Polystyrene Substances 0.000 claims abstract description 7
- 229920000728 polyester Polymers 0.000 claims abstract description 7
- 229920002223 polystyrene Polymers 0.000 claims abstract description 7
- 125000003118 aryl group Chemical group 0.000 claims abstract description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 3
- 238000007306 functionalization reaction Methods 0.000 claims description 69
- 239000000203 mixture Substances 0.000 claims description 47
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 39
- 239000002243 precursor Substances 0.000 claims description 38
- 229920001282 polysaccharide Polymers 0.000 claims description 28
- 239000005017 polysaccharide Substances 0.000 claims description 28
- 150000004676 glycans Chemical class 0.000 claims description 27
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 25
- 229910052739 hydrogen Inorganic materials 0.000 claims description 25
- 239000001257 hydrogen Substances 0.000 claims description 22
- 125000003277 amino group Chemical group 0.000 claims description 19
- 229920001577 copolymer Polymers 0.000 claims description 19
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 17
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 17
- 239000012429 reaction media Substances 0.000 claims description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 16
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 15
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 15
- 125000005843 halogen group Chemical group 0.000 claims description 15
- 150000002772 monosaccharides Chemical group 0.000 claims description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 14
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 13
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 13
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- 239000000178 monomer Substances 0.000 claims description 13
- 230000008569 process Effects 0.000 claims description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
- 125000001246 bromo group Chemical group Br* 0.000 claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 12
- 238000006352 cycloaddition reaction Methods 0.000 claims description 11
- 239000002609 medium Substances 0.000 claims description 11
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 150000003573 thiols Chemical class 0.000 claims description 11
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 10
- 150000008064 anhydrides Chemical class 0.000 claims description 10
- 150000007942 carboxylates Chemical class 0.000 claims description 10
- 229910052802 copper Inorganic materials 0.000 claims description 10
- 150000002430 hydrocarbons Chemical group 0.000 claims description 10
- 239000012948 isocyanate Substances 0.000 claims description 10
- 150000002513 isocyanates Chemical class 0.000 claims description 10
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims description 10
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 claims description 10
- 239000004215 Carbon black (E152) Substances 0.000 claims description 9
- 235000001014 amino acid Nutrition 0.000 claims description 9
- 150000001413 amino acids Chemical class 0.000 claims description 9
- 229930195733 hydrocarbon Natural products 0.000 claims description 9
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 8
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 8
- 150000002431 hydrogen Chemical class 0.000 claims description 8
- 230000007246 mechanism Effects 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 229920001451 polypropylene glycol Polymers 0.000 claims description 8
- 239000000741 silica gel Substances 0.000 claims description 8
- 229910002027 silica gel Inorganic materials 0.000 claims description 8
- 125000004429 atom Chemical group 0.000 claims description 7
- 238000004587 chromatography analysis Methods 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 6
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 6
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 claims description 6
- 150000002334 glycols Chemical class 0.000 claims description 6
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 239000002798 polar solvent Substances 0.000 claims description 6
- 239000002453 shampoo Substances 0.000 claims description 6
- 229910052710 silicon Inorganic materials 0.000 claims description 6
- 239000010703 silicon Substances 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 229920002857 polybutadiene Polymers 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 4
- 239000004593 Epoxy Substances 0.000 claims description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- 239000003599 detergent Substances 0.000 claims description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 4
- 150000004756 silanes Chemical class 0.000 claims description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 claims description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 3
- QIGJYVCQYDKYDW-UHFFFAOYSA-N 3-O-alpha-D-mannopyranosyl-D-mannopyranose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(CO)OC(O)C1O QIGJYVCQYDKYDW-UHFFFAOYSA-N 0.000 claims description 3
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 claims description 3
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-PZPXDAEZSA-N 4β-mannobiose Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-PZPXDAEZSA-N 0.000 claims description 3
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- 229920002101 Chitin Polymers 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 3
- WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 claims description 3
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 3
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 claims description 3
- 229930091371 Fructose Natural products 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims description 3
- 229920000926 Galactomannan Polymers 0.000 claims description 3
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims description 3
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 claims description 3
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 3
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 claims description 3
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 3
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 claims description 3
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 claims description 3
- 229920002000 Xyloglucan Polymers 0.000 claims description 3
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 claims description 3
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 claims description 3
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 3
- FBJQEBRMDXPWNX-SMGIPPFUSA-N alpha-D-Galp-(1->6)-alpha-D-Galp-(1->6)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-SMGIPPFUSA-N 0.000 claims description 3
- LHAOFBCHXGZGOR-NAVBLJQLSA-N alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1 LHAOFBCHXGZGOR-NAVBLJQLSA-N 0.000 claims description 3
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 claims description 3
- BNABBHGYYMZMOA-AHIHXIOASA-N alpha-maltoheptaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O BNABBHGYYMZMOA-AHIHXIOASA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- QLTSDROPCWIKKY-PMCTYKHCSA-N beta-D-glucosaminyl-(1->4)-beta-D-glucosamine Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O)[C@@H](CO)O1 QLTSDROPCWIKKY-PMCTYKHCSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 3
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 claims description 3
- 229920001400 block copolymer Polymers 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 235000010980 cellulose Nutrition 0.000 claims description 3
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 229930182830 galactose Natural products 0.000 claims description 3
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 claims description 3
- 229960002442 glucosamine Drugs 0.000 claims description 3
- 229940097043 glucuronic acid Drugs 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- 150000002453 idose derivatives Chemical class 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 3
- FBJQEBRMDXPWNX-FYHZSNTMSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-FYHZSNTMSA-N 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- QIGJYVCQYDKYDW-LCOYTZNXSA-N laminarabiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O QIGJYVCQYDKYDW-LCOYTZNXSA-N 0.000 claims description 3
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 claims description 3
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 claims description 3
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 claims description 3
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 claims description 3
- 229920002245 Dextrose equivalent Polymers 0.000 claims description 2
- 108010024636 Glutathione Proteins 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- 229920000881 Modified starch Polymers 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 claims description 2
- 229940072107 ascorbate Drugs 0.000 claims description 2
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 claims description 2
- 229910052804 chromium Inorganic materials 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- 239000003480 eluent Substances 0.000 claims description 2
- 229960003180 glutathione Drugs 0.000 claims description 2
- 238000011065 in-situ storage Methods 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 229910052748 manganese Inorganic materials 0.000 claims description 2
- 235000019426 modified starch Nutrition 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 239000012454 non-polar solvent Substances 0.000 claims description 2
- 239000007764 o/w emulsion Substances 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 229920005604 random copolymer Polymers 0.000 claims description 2
- 230000003381 solubilizing effect Effects 0.000 claims description 2
- PZDOWFGHCNHPQD-VNNZMYODSA-N sophorose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-VNNZMYODSA-N 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 150000002924 oxiranes Chemical class 0.000 claims 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims 2
- 229940113088 dimethylacetamide Drugs 0.000 claims 2
- 239000004698 Polyethylene Substances 0.000 claims 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical class CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims 1
- 239000003880 polar aprotic solvent Substances 0.000 claims 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 239000003586 protic polar solvent Substances 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 239000003995 emulsifying agent Substances 0.000 abstract description 4
- 238000006243 chemical reaction Methods 0.000 description 18
- 150000002118 epoxides Chemical class 0.000 description 13
- 239000011734 sodium Substances 0.000 description 12
- 239000010949 copper Substances 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 150000001345 alkine derivatives Chemical class 0.000 description 10
- 238000006736 Huisgen cycloaddition reaction Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 7
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 150000002482 oligosaccharides Chemical class 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 238000004809 thin layer chromatography Methods 0.000 description 7
- 238000006459 hydrosilylation reaction Methods 0.000 description 6
- 150000002825 nitriles Chemical class 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 150000001540 azides Chemical class 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000004949 mass spectrometry Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 229920001542 oligosaccharide Polymers 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 150000003852 triazoles Chemical class 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 240000008886 Ceratonia siliqua Species 0.000 description 4
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 4
- 101000641959 Homo sapiens Villin-1 Proteins 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 102100033419 Villin-1 Human genes 0.000 description 4
- 150000001412 amines Chemical group 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- 238000010511 deprotection reaction Methods 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 150000002338 glycosides Chemical group 0.000 description 4
- 238000003760 magnetic stirring Methods 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- JKANAVGODYYCQF-UHFFFAOYSA-N prop-2-yn-1-amine Chemical compound NCC#C JKANAVGODYYCQF-UHFFFAOYSA-N 0.000 description 4
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 4
- 235000010378 sodium ascorbate Nutrition 0.000 description 4
- 229960005055 sodium ascorbate Drugs 0.000 description 4
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 4
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229910018557 Si O Inorganic materials 0.000 description 3
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 3
- 150000001719 carbohydrate derivatives Chemical class 0.000 description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000002781 deodorant agent Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000003408 phase transfer catalysis Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920002050 silicone resin Polymers 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 150000003536 tetrazoles Chemical class 0.000 description 3
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 125000004181 carboxyalkyl group Chemical group 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 2
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 229920000578 graft copolymer Polymers 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 210000004417 patella Anatomy 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical class O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- 125000000923 (C1-C30) alkyl group Chemical group 0.000 description 1
- KFEUJDWYNGMDBV-UHFFFAOYSA-N (N-Acetyl)-glucosamin-4-beta-galaktosid Natural products OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 KFEUJDWYNGMDBV-UHFFFAOYSA-N 0.000 description 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 1
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-CBPJZXOFSA-N 2-amino-2-deoxy-D-mannopyranose Chemical compound N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-CBPJZXOFSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 241000219748 Cyamopsis Species 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 238000005873 Huisgen reaction Methods 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- KFEUJDWYNGMDBV-LODBTCKLSA-N N-acetyllactosamine Chemical group O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KFEUJDWYNGMDBV-LODBTCKLSA-N 0.000 description 1
- HESSGHHCXGBPAJ-UHFFFAOYSA-N N-acetyllactosamine Natural products CC(=O)NC(C=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O HESSGHHCXGBPAJ-UHFFFAOYSA-N 0.000 description 1
- 229910003849 O-Si Inorganic materials 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 229910003872 O—Si Inorganic materials 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- GZCGUPFRVQAUEE-UHFFFAOYSA-N alpha-D-galactose Natural products OCC(O)C(O)C(O)C(O)C=O GZCGUPFRVQAUEE-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000003254 anti-foaming effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001773 cellobioses Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010549 co-Evaporation Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000007957 coemulsifier Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 125000005388 dimethylhydrogensiloxy group Chemical group 0.000 description 1
- 229960001275 dimeticone Drugs 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 230000008863 intramolecular interaction Effects 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003961 organosilicon compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920000548 poly(silane) polymer Polymers 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003138 primary alcohols Chemical group 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical group CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/38—Polysiloxanes modified by chemical after-treatment
- C08G77/382—Polysiloxanes modified by chemical after-treatment containing atoms other than carbon, hydrogen, oxygen or silicon
- C08G77/388—Polysiloxanes modified by chemical after-treatment containing atoms other than carbon, hydrogen, oxygen or silicon containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
- A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/22—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
- C08G77/26—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen nitrogen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/42—Block-or graft-polymers containing polysiloxane sequences
- C08G77/46—Block-or graft-polymers containing polysiloxane sequences containing polyether sequences
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Definitions
- the present invention relates to novel hybrid structures comprising at least one silicone entity -SiI- (for example polymer: eg polyorganosiloxane-POS) and at least one entity B which can be of various nature: hydrocarbon or mineral-for example oligomer or polymer-in particular polyol (Po).
- entity SiI for example polymer: eg polyorganosiloxane-POS
- entity B which can be of various nature: hydrocarbon or mineral-for example oligomer or polymer-in particular polyol (Po).
- the link or links between this entity SiI and this entity B are obtained according to the chemical mechanism designated by the name "click chemistry", in which an azide (or azide) reactive unit reacts with a reactive unit of the alkynyl or nitrile type, for form a triazole or tetrazole bond (Ro).
- the invention also relates to the process for obtaining these hybrid structures as well as their applications as amphiphilic compounds, for example.
- synthons that is to say the intermediate products bearing azide and / or alkynyl and / or nitrile type functions and involved in the preparation of these hybrid structures.
- Silicones of the Siil entity are in particular POS polymers. These are a class of polymers of major interest in multiple industrial sectors. The most common group is linear poly (dimethylsiloxane) or PDMS (POS type MDM). The second largest group of silicone materials is silicone resins
- POS type MDTM, MQ formed by oligo or polysiloxane branched or cage-shaped.
- POS is an easily accessible raw material, they are also characterized by their hydrophobic properties.
- Silicones provide a wide variety of materials. Their consistency ranges from liquid to hard plastic, including gel and gum. Silicones are present everywhere in everyday life, in the form of sealants, glues, seals, anti-foaming additives for detergent powders, cosmetics, medical equipment, electrical cable sheaths, high-performance greases, etc.
- sealants glues, seals, anti-foaming additives for detergent powders, cosmetics, medical equipment, electrical cable sheaths, high-performance greases, etc.
- Siil entity within the meaning of the invention may also contain silicon-based inorganic material such as silica or (poly) silanes.
- the entity B can include in particular polyols and more especially, but not exclusively, oligosaccharides or polysaccharides (linear, branched or cyclic) at least partly constituted by at least two, preferably at least three monosaccharide units, connected to each other by osidic bonds.
- polysaccharides are of interest in view of their physicochemical properties (hydrophilic, hydrolyzable, bioabsorbable ...) their chemical complexity offering multiple possibilities in terms of structure and properties, their great availability and their natural origin, among others. This natural origin can make them particularly attractive from an environmental and / or toxicological and / or commercial point of view.
- polysaccharides such as starch products and their derivatives or cellulosic products and their derivatives are plethoric.
- hybrid structures based on polysaccharides and POS so as to have, for example, emulsifying compounds that can be used in particular in cosmetic compositions such as skin care compositions, protective compositions and the like. and solar treatment, shampoo compositions, deodorant compositions and / or antiperspirant, for example in the form of "stick", gel or lotion, among others.
- the polysaccharide entity and the POS entity combine their respective advantages.
- the polysaccharide entity by the presence of its numerous hydroxyl functions, can develop strong intra or intermolecular interactions, both in a hydrophobic medium and in a hydrophilic medium. This behavior of molecular recognition type makes it possible to obtain gels-type organizations and / or to promote interactions with polar surfaces such as textiles (ie cotton), hair.
- the POS entity brings two major benefits. The first is the flexibility which gives this POS entity a high reactivity and an ability to adapt its molecular conformation according to the substrate (s) present.
- the second advantage is due to the hydrophobic character of this POS entity which brings low surface energy properties.
- Wacker-Belsil® SPG 128 VP is a cyclopentadimethylsiloxane of which a part of the siloxy units D is substituted by a polyglucoside chain connected to silicon by a ball joint comprising two oxygen bridges and of which another part of the units D is substituted with an alkyl radical of - (CH) type. 2 ) W -CH 3 , w being a natural integer.
- EP-BO 612 759 describes organosilicon compounds comprising a glycoside residue obtained by reacting a mono- or polysaccharide (1 to 10 monosaccharide units) alkenylated with a POS, for example a disiloxane, bearing SiH units.
- the alkenyl group is introduced directly on the oligosaccharide or polysaccharide, unprotected anomer position, with alkyl oxyethanol, in the presence of a strong acid, to 100 0 C.
- the hydrosilylation is carried out at the Speier platinum catalyst aid in isopranol at 100 ° C.
- the hybrid compound obtained in the examples has the following formula:
- WO-A-2005/087843 discloses a graft polymer comprising a polyorganosiloxane backbone and glycoside units (mono and / or polysaccharides).
- WO-A-2005/087843 describes the preparation of an allyl-functionalized cellobiose grafted polydimethylsiloxane. To do this, the cellobiose is reacted with allylamine. After fixing the allylamine unit on the anomeric cellobiose carbon, the amine function and a part of the primary hydroxyls are protected by acetylation. The remaining hydroxyl functions are protected by substitution of their hydrogen by a trimethylsilyl function.
- the hydrosilylation of polydimethylsiloxane end dimethylhydrogensiloxy is then carried out in the presence of Karstedt platinum at a temperature of 70 0 C. This is followed by deprotection of the grafted POS at its ends by the disaccharide cellobiose, using a tetrahydrofuran / methanol mixture in an acid medium.
- the reaction scheme is as follows:
- saccharide protection / deprotection constraints are a definite handicap for these known polyorganosiloxane / glycoside graft polymers and their process for obtaining them.
- Huisgen and Szeimies [(a) Huisgen, R .; Szeimies, G .; Moebius, L. Chem. Ber. 1967, 100, 2494. (b) Huisgen, R .; Knorr, R .; Moebius, L .; Szeimies, G. Chem. Ber. 1965, 98, 4014] were the first to carry out the 1,3-dipolar cycloaddition of an azido derivative on an alkyne derivative at high temperature. The scheme of this cycloaddition is as follows:
- products 1 to 10) comprising, on the one hand, phenyl rings and, on the other hand, inert or branched, optionally unsaturated and optionally hydroxyl-bearing cyclic molecules, and a hybrid system (11) comprising a connecting triazole coupling on the one hand, a propane diol residue and, on the other hand, a dihydroxy cyclic compound.
- a hybrid system (11) comprising a connecting triazole coupling on the one hand, a propane diol residue and, on the other hand, a dihydroxy cyclic compound.
- WO-A-03/101972 does not disclose hybrid compounds comprising cycloaddition linked entities "" click chemistry "to different polyol entities or POS entities, polyalkylene glycol, polyamide, polyester, alkyl, alkenyl, alkynyl, aryl and their combinations, nor to mineral materials such as silica.
- the application WO-A-2005/118625 discloses other applications of the "click chemistry" 1,3-dipolar cycloaddition aimed at producing hybrid systems comprising an entity A corresponding to a carbohydrate linked by a 5-membered cyclic ring. 1,2,3-triazole at an entity B consisting of an amino acid or an amino acid analogue or at a C entity representing a polypeptide or polypeptide analogue.
- These hybrid systems are obtained by reacting the functionalized carbohydrate with an acetylene function or with an azide and an amino acid or a polypeptide functionalized with a corresponding amide or acetylene function.
- carbohydrate designates both mono and polysaccharides, in which the hydroxyl groups are optionally substituted with hydrogen, an amino group, thiol or groups of hetero atoms.
- the 1,3-dipolar cycloaddition is carried out by protecting the hydroxyl groups of the saccharide with an acetyl group and the amino group of the amino acid with a Boc group, and by using a copper catalyst and diisopropylethylamine in a tetrahydrofuran solvent medium.
- the pseudo-glycoamino acids and glycopeptides obtained can be used for the treatment of bacterial conditions.
- One of the essential objectives of the present invention is to provide other hybrid compounds obtained by "click chemistry”.
- Another essential objective of the invention is to provide novel hybrid compounds based on Siil silicone entity (s) connected (s) by at least one triazole or pentacyclic tetrazole to at least one identical or different entity B (eg polyol ), these hybrid compounds being capable of being exploited in many applications, both industrial (emulsifiers) and biological.
- Another essential objective of the invention is to provide hybrid compounds comprising one or more SiI silicone entities, linked by triazole or tetrazole pentacyclic patella obtained by "click chemistry" to at least one B-entity of (polymer) -polyol type, for example polysaccharide and / or of POS type, and / or of polyalkylene glycol, and / or of polyamine (peptides), and / or polyester, and / or polystyrene, and / or alkyl, and / or alkenyl, and / or alkynyl, and / or aryl, and / or mineral such as silica.
- B-entity of (polymer) -polyol type for example polysaccharide and / or of POS type, and / or of polyalkylene glycol, and / or of polyamine (peptides), and / or polyester, and / or polystyrene, and / or alky
- Another essential objective of the invention is to provide hybrid polysaccharide / POS compounds linked by at least one patella resulting from a 1,3-dipolar cycloaddition of an azido or nitrile derivative on an alkyne derivative, with a copper catalysis. by "click chemistry”.
- Another essential object of the invention is to provide hybrid compounds comprising one or more Po (polymer) -polyols, for example polysaccharide, entities, these compounds being capable of being prepared without heavy steps of protection / deprotection of the reagents, in particular saccharides.
- Po polymer
- polyols for example polysaccharide
- Another essential objective of the invention is to provide a simple process for the preparation of Sil / B hybrid compounds without heavy steps of protection / deprotection of the reagents, in particular saccharides in the case where the latter are present in B.
- Another essential object of the invention is to provide cosmetic compositions, shampoo compositions, cleaning compositions, comprising hybrid compounds as defined in the objectives above.
- Ro is a ball of formula (IL1) or (II.2) below:
- IL1 (IL2) with Z representing a carbon or nitrogen atom;
- B is a mineral or organic entity, optionally a polymer; and in case of presence of a plurality of entities B per molecule of hybrid compound, said entities B are identical or different from each other.
- hybrid designates homogeneous Sil-Ro-B structures (SiI is identical to B) or heterogeneous structures (SiI is different from B).
- Z represents a carbon atom, it is also bonded to a hydrogen atom not usually represented, so as to satisfy its valence.
- the hybrid compound according to the invention is characterized in that the Ro ball or at least one of the Ro ball joints is connected to the Siil entity and / or the B entity by a -L- divalent link.
- L is a spacing pattern.
- L may for example be a hydrocarbon unit or an atom such as O or S.
- the term “hydro (geno) carbon unit” designates a unit comprising, for example, at least one carbon atom and / or or at least one hydrogen. This includes the bonds "ester", “amide”, “imine” ... These new hybrid compounds are easy to build with an acceptable cost price.
- hybrid compounds that are the POS and -Ro-polysaccharide or -R-alkyl associations, represent a new group of structures particularly interesting in terms of compatibility with industrial requirements, including cost and impact on the environment and terms of application.
- the present invention also provides a novel process for obtaining the abovementioned hybrid compounds.
- the Siil-X synthon is reacted with the BY synthon according to a cycloaddition mechanism, so as to obtain a Sil ⁇ Ro ⁇ B hybrid compound comprising at least one SiI entity in which at least one Siil silicon is substituted with at least one set of the following general formula (T): ⁇ - -; with Ro and B as defined above;
- reaction medium is separated from the reaction medium so as to recover it.
- Such a method is particularly advantageous because of its simplicity, its economy, its eco-compatibility and the multiplicity (variety) of the products that it makes it possible to obtain.
- SiI-XY synthons can be used instead of or in addition to the SiI-X synthons and BY synthons, each comprising at least one reactive unit X and at least one least one reactive Y motif and mixed B-XY synthons each comprising at least one reactive unit X and at least one reactive unit Y, such that these SiI-XY and B-XY synthons are able to react together or on themselves.
- the invention also relates to:
- SiI may comprise at least one residue functionalized by at least one functionalization group belonging to the group comprising the carboxylic, carboxylate, anhydride, thiol, isocyanate and epoxide functionalization groups with: -> Li comprising at least one amino group (for example terminal) having reacted with the functionalization group (s) of SiI, ⁇ and / or Li resulting from a precursor comprising at least one halo group (for example bromo) having reacted with the group or groups (s) functionalization of SiI; -> and / or Li is derived from the precursor NaN 3 reacted with the (or) group (s) functionalization of SiI epoxide type;
- SiI comprises at least one residue (for example POS) functionalized by at least one functionalization group belonging to the group comprising hydrogen and the units bearing at least one ethylenic unsaturation, with Li comprising at least one a group (for example terminal) bearing at least one ethylenic unsaturation and / or at least one hydrogen, having reacted with the corresponding functionalization group (s) of SiI;
- residue for example POS
- Li comprising at least one a group (for example terminal) bearing at least one ethylenic unsaturation and / or at least one hydrogen
- Li comprising at least one amino group (for example terminal) having reacted with the functionalization group (s) of SiI, and / or Li resulting from a precursor comprising at least one halo group (for example bromo) having reacted with the functionalization group (s) of the SU; and / or Li is derived from the NaN 3 precursor reacted with the epoxide-type Siil functionalization group (s); SiI-Y synthons comprising a reactive unit Y having at least one reactive end of formula (VII.2.1):
- SiI may comprise at least one functionalized residue by at least one functionalization group belonging to the group comprising carboxylic, carboxylate, anhydride, thiol, isocyanate and epoxide functionalization groups with:
- ⁇ and / or L 2 from a precursor comprising at least one halogeno group (for example bromo) having reacted with the functionalization group (s) of SiI;
- halogeno group for example bromo
- SiI comprises at least one residue (for example POS) functionalized by at least one functionalization group belonging to the group comprising hydrogen and the units carrying at least one ethylenic unsaturation, with L 2 comprising at least one at least one group (for example terminal) bearing at least one ethylenic unsaturation and / or at least one hydrogen, which has reacted with the corresponding functionalization group (s) of SiI;
- residue for example POS
- L 2 comprising at least one at least one group (for example terminal) bearing at least one ethylenic unsaturation and / or at least one hydrogen
- SiI-XY mixed synthons in which the X and Y reactive units correspond to the same definitions as those given above for the Siil-X and SiI-Y synthons;
- the invention finally relates to the uses of these hybrid compounds and the compositions comprising them.
- the Ro bonded joint of formula (IL1) or (II.2) is at the heart of the hybrid compounds according to the invention.
- the free valency bond of nitrogen at position 1 in formulas (IL1) and (II.2) connects Ro to SiI and the free valence bond of carbon or Z atom in position 4 or 5 in formulas (IL1) and (II.2) connects Ro to B.
- the free valency bond of nitrogen in position 1 in formulas (IL1) and (II.2) connects Ro to B and the free valence bond of carbon or Z atom in position 4 or 5 in formulas (IL1) and (II.2) connects Ro to SiI.
- hybrid compounds according to the invention are not limited to compounds comprising a single Ro ball, but also cover hybrid compounds each comprising several Ro balloons, identical or different from each other.
- the ball joint Ro or at least one of the ball joints Ro is connected to the entity Siil and / or to the entity B by a divalent link -L-
- the latter can comprise in particular at least one of the Li, L 2 , L 3 , L 4 bonds, as defined above in the formulas (VIL 1.1). (VII.2.1). (VIL 1.3). (VII.2.4) synthons SiI-X, S
- the simplified general formulas of the corresponding hybrid compounds may be, inter alia, those belonging to the group comprising: SiI-L 1 -Ro-L 2 -SiI; SiI-L 1 - Ro-L 4 - B; Siil -L 2 -Ro-L 3 -B; BL 3 -Ro-L 4 - B; L 1 , L 2 , L 3 , L 4 being spacing patterns, taken singly or together being identical or different from each other.
- the Siil entity comprises at least one POS carrying siloxy units M, D, T and / or Q, preferably at least one POS carrying siloxy units M and D, optionally T and / or or Q, and even more preferably at least one POS of type M (D) dM, M (D) d (T) t M, MQ, with d, t rational numbers greater than or equal to 0.
- d is for example understood between 1 and 1,000,000, preferably from 1 to 10,000
- t is for example between 0 and 50, preferably between 0 and 20.
- these POS are for example linear polysiloxanes ⁇ , 0> functions Is or functionalised in the chain.
- POS can also be more or less branched structures.
- these POS are, for example, carrying epoxy function (eg glycidyl ether) and / or hydrogen and / or alkenyl (eg vinyl) and / or alkynyl.
- the SiI entity comprises silicone resins (POS type MDTM, MQ), formed by branched or cage-shaped oligo or polysiloxanes.
- POS especially referred resins are those comprising siloxy units M: (R 3 Si0i / 2), and optionally D: (R 2 Si0 2/2) and / or T: (RSiO 3/2), said resins being by Moreover functionalized, that is to say, they comprise units M '(Y y R 3-y SOI / 2) and optionally D': (ry ⁇ io 2/2) and / or T '(YSiO 3 / 2);
- These functional silicone resins MQ can be liquid or solid at room temperature. They have been known for a very long time and are currently used in many applications such as, for example, in electrical insulating varnishes, heat-resistant coatings, encapsulating materials for semiconductor components, etc.
- the functional POS MQ resins (MM'Q) whose production is the subject of the present invention may also comprise siloxyl units D and / or T, or functionalized siloxyl units D 'and / or T'.
- the Siil entity comprises silicic mineral material, such as silica.
- the Siil entity comprises (poly) silanes.
- the polysilanes can be linear, branched or crosslinked.
- B is a mineral or organic entity, optionally a polymer; and in case of presence of a plurality of entities B per molecule of hybrid compound, said entities B are identical or different from each other, the organic entity B then preferably being chosen or preferably coming from a compound chosen from the group comprising:
- the synthetic polymers of the entity B may be synthetic polymers of average molar mass greater than 1000 g / mol, preferably greater than 10000 g / mol.
- B is chosen or is derived from a compound selected from the group consisting of: • polyols, their copolymers or monomeric units making it possible to obtain them;
- Silicones in particular polyorganosiloxanes (POS), their copolymers or the monomer units making it possible to obtain them, or else a mineral material based on silicon such as silica or (poly) silanes;
- Polyalkylene glycols (or alternatively alkylene polyoxides), preferably polyethylene glycols (or ethylene polyoxides) and / or polypropylenes glycols (or propylene polyoxides), and / or polytetraethylene glycols, and / or their copolymers or co-oligomers, in particular random or block copolymers or co-oligomers, or polypropylene glycols and polypropylene glycols (or alternatively random or block ethylene and propylene polyoxides), these polyalkylene glycols being optionally functionalized with or on other groups, for example by or on amino groups (Jeffamines), and / or being optionally terminated on at least one end by a hydroxyl group or by an alky
- polyesters their copolymers or the monomeric units making it possible to obtain them
- Polybutadienes their copolymers or monomeric units making it possible to obtain them
- polyols that may be included in the B entity, it is (are) selected (s), preferably from the saccharides in the broad sense and / or from the polyols non-saccharides, for example synthetic polymeric non-saccharide polyols.
- the synthetic polymeric non-saccharide polyols may in particular have an average molecular weight of greater than 1000 g / mol, preferably greater than 10000 g / mol.
- the latter are, for example, polyhydroxyaldehydes H- [CHOH] n -CHO or polyhydroxyketones H- [CHOH] n -CO- [CHOH] m -H preferably comprising at least 3 carbon atoms.
- the synthetic polymeric non-saccharidic polyols preferably have at least 3 hydroxyl units, preferably at least 4, preferably at least 10. They preferably have at least 3 repeating units, preferably at least 4, preferably at least 10.
- saccharide also known as “carbohydrates”
- saccharide includes, it will be understood, monosaccharides, disaccharides, oligosaccharides and polysaccharides as well as all saccharide derivatives
- Saccharides are known to those skilled in the art. It is known in particular that the saccharides have a non-reducing end and a reducing end. The latter implies the presence of an "anomeric carbon" and is on the right according to the writing convention. It is also known that saccharides have OH groups.
- the carbon of the saccharide more preferably contained in the (the) bond (s) with the (the) ball (s) Ro is the "anomeric” carbon. This does not exclude that all or part of the other saccharide carbons can be connected to a Ro ball. This is all the more possible as the groups carried by the "non-anomeric" carbons do not require protection during the synthesis of the hybrid compound.
- Monosaccharides are molecules comprising a single saccharide unit (for example C5: pentose or C6: hexose), without glycosidic connection between several units of this type.
- Monosaccharides include, among others, aldoses, dialdoses, aldoketoses, ketoses, dicetoses, as well as deoxysaccharides, aminosaccharides and their derivatives resulting from precursors comprising at least one carbonyl group.
- saccharides D-glucose, fructose, sorbose, mannose, galactose, talose, allose, gulose, idose, glucosamine, mannosamine, galactosamine, glucuronic acid, rhamnose, arabinose, galacturonic acid, fucose, xylose, lyxose, ribose.
- di- or oligosaccharides examples include the following saccharides: di-saccharides: maltose, gentiobiose, lactose, cellobiose, isomaltose, melibiose, laminaribiose, chitobiose, xylobiose, mannobiose, sophorose, palatinose oligo-saccharides: maltotriose, isomaltotriose, maltotetraose, maltopentaose, xyloglucan, maltoheptaose, mannotriose, manninotriose, chitotriose, in general, the di- or oligosaccharides having, for example, ⁇ -1-4, ⁇ -1-4 or ⁇ -1-6 bonds.
- the polysaccharides according to the invention may be linear or branched and may comprise, for example, more than 20 monosaccharide residues or preferably more than 30 monosaccharide residues or even more particularly between 25 and 100 monosaccharide residues. These may be the same or different from each other.
- the polysaccharides according to the invention may contain linear units mono-, di-, tri-, tetra-, penta-, hexa-, hepta-, octa-, nona- or decasaccharides, preferably mono-, di-, tri- or tetrasaccharides.
- the polysaccharides may comprise at least two, or at least three or at least four, or at least ten, to substantially more in the case of polysaccharide polymer, such linear units.
- the polysaccharides according to the invention may comprise recurring saccharide units of N-acetyl-lactosamine type or acetylated saccharide units.
- Exemplary polysaccharides include: starch (preferably having at least 5 DE equivalent) and derivatives thereof such as maltodextrins, cyclodextrins and glucose syrups, pectin; cellulose and its derivatives; galactomannans, for example guar or carob polymers and their derivatives,
- the guar or carob macro-molecule is constituted by a linear main chain constructed from monomeric ⁇ -D-mannose sugars linked together by (1-4) bonds, and ⁇ -D-galactose side units linked to ⁇ -D-mannoses by bonds (1-6).
- Natural guar is extracted from the albumen of certain plant seeds, eg Cyamopsis Tetragonalobus.]; chitin and chitosan bacterial polysaccharides hyaluronic acid.
- the entity B is different from a maltodextrin. According to a particular embodiment, the entity B is different from a cyclodextrin.
- the starch or cellulosic polysaccharides likely to be part of the constitution of entity B are preferably of natural origin, but could also be obtained synthetically.
- saccharide derivatives mention may be made in particular of: • those obtained by reduction of the carbonyl group (alditol),
- Those obtained by grafting one or more groups for example carboxylic acid groups, carboxyalkyl (e.g., carboxymethyl) groups, hydroxyalkyl (e.g., hydroxyethyl) groups or else alkyl (e.g., methyl) groups;
- carboxylic acid groups for example carboxylic acid groups, carboxyalkyl (e.g., carboxymethyl) groups, hydroxyalkyl (e.g., hydroxyethyl) groups or else alkyl (e.g., methyl) groups;
- Glycosides namely compounds comprising at least one saccharide and at least one non-saccharide compound, the saccharide (s), on the one hand, and the non-saccharide component (s) (s) ), on the other hand, being connected to each other (or to each other) by hydrolyzable bonds
- Galactomannan derivatives in particular derivatives of guar polymers or of carob polymers, obtained by hydrolysis of guar or carob, and possibly by chemical modification (derivatization).
- Derivatisation can be used to chemically modify saccharide derivatives other than those mentioned above.
- the polyols likely to enter the constitution of entity B are chosen:
- saccharides comprising at least two, preferably at least three monosaccharide units, the preferred mono or polysaccharides being those selected from the group comprising:
- maltotriose isomaltotriose, maltotetraose, maltopentaose, xyloglucan, maltoheptaose, mannotriose, manninotriose, chitotriose, starches (preferably those having at least 5 dextrose equivalents) and starch derivatives such as maltodextrins and glucose syrups, celluloses, galactomannans, chitin and chitosan
- One of the major advantages of the invention is that of proposing hybrid compounds the synthesis of which does not require protection of sensitive groups, in particular those carried by the saccharides of the SiI or B entity.
- the entity B can also include polyalkylene glycol type residues optionally having at least one alkyl ether terminus, for example methyl ether.
- polyalkylene glycols include polyoxyethylene glycols, polyoxyethylene glycols monoalkyl (e.g., methyl) ether, polyoxypropylene glycols, polyoxypropylene glycols monoalkyl (e.g., methyl) ether, polyoxytetraethylene glycols ...
- the polyamides may be constituent elements of the entity B.
- Examples of polyamides that may be mentioned include polyamides 6-6, polyamides 6, polyamides 6 monoamine, polyamines 6-10, polyamides 12-12.
- the polyesters may be constituent elements of the B entity.
- polyesters that may be mentioned include poly ⁇ -caprolactone, polylactic acid, ethylene glycol polyadipate and polyhydroxyalkanoate.
- Polystyrenes may be constituent elements of entity B.
- Examples of polystyrenes include hydroxytelechelic or mono-functional polystyrene ...
- Polybutadienes may be constituent elements of entity B.
- Examples of polybutadienes include hydroxytelechelic polybutadiene ...
- amino acids and peptides may be constituent elements of the entity B.
- peptides designates, inter alia, oligopeptides and polypeptides, or even proteins.
- derivatives (or analogs) of amino acids (natural or synthetic) and peptides are also covered by the invention as entity B.
- All (co) polymers capable of forming part of the entity B of the hybrid compound SiI-Ro-B may be linear or branched or crosslinked homopolymers, or else linear or branched, optionally crosslinked, block or random block copolymers. .
- the BX or BY synthon used to prepare the hybrid compound comprises a finished (co) polymer or a monomer, oligomer or unfinished polymer unit, intended to grow to form a polymer. finished after reaction with SiI-Y or SiI-X.
- the alkyl, alkenyl or alkynyl chains that may be included in the B-entity comprise, for example, from 2 to 50 carbon atoms, preferably from 4 to 40, and more preferably from 4 to 30 carbon atoms.
- Silica is an example of a mineral material that can enter into the constitution of entity B.
- the entity B comprises polymers or copolymers chosen from the group as mentioned above, or even linear or branched chains, optionally crosslinked.
- the molar mass of this entity B is greater than or equal to 100, preferably greater than or equal to 100, and even more preferably between 100 and 50000.
- the hybrid compound Sil ⁇ Ro ⁇ B meets at least one of the following formulas: in which:
- R 2 which is identical or different, is a hydrogenocarbon group, preferably a methyl group,
- R 3 is a group of formula -Sil-B in which Ro and Po are as defined above, - R 1 , identical or different, is a group R 2 or R 3 ,
- R is a divalent group comprising an oxygen atom, preferably a group -O-,
- n 1
- - n is an average number greater than or equal to 0
- - k and 1 are average numbers greater than or equal to 0
- o and p are average numbers greater than or equal to 0.
- m + n is between 0 and 1000000, preferably between 0 and 10000, the ratio between m and n being between 1/1 and 1/100, preferably between 1/20 and 1/50, or
- - m + n + o + p is between 0 and 1000, preferably between 0 and 300, the ratio between n + o and m + p being between 1/1 and 1/100, preferably between 1/20 and 1/50.
- the invention relates to a process for obtaining hybrid compounds and especially those according to the invention, as described above.
- This method of obtaining is that defined above. It comprises the four steps (i), (ii), (iii), (iv), which are detailed below by way of non-limiting illustration.
- SiI-X starting synthons 1.
- SiI may comprise at least one residue functionalized by at least one functionalization group belonging to the group comprising carboxylic, carboxylate, anhydride, thiol functionalization groups.
- Li having at least one amino group (for example a terminal group) having reacted with the functionalization group (s) of the SiI,
- SiI comprises at least one remainder (for example POS) functionalized by at least one functionalization group belonging to the group comprising hydrogen and the units carrying at least one ethylenic unsaturation, with Li comprising at least one group (for example terminal) bearing at least one ethylenic unsaturation and / or at least one hydrogen, reacted with the or the corresponding functionalization group (s) of SiI; 3. according to a third possibility, the first two possibilities are combined.
- remainder for example POS
- Li comprising at least one group (for example terminal) bearing at least one ethylenic unsaturation and / or at least one hydrogen
- this Siil-X synthon can be characterized in that SiI is a polymer comprising, for example, at least two, preferably at least 3, and even more preferably at least 10 monomer (siloxy) units.
- the preparation of the Siil-X synthon can advantageously comprise the following essential sub-steps: a-reaction of a SiI hydrogen and / or another (or other) Siil functionalization group (s) with an excess at least one precursor of the Li bond carrying a reactive end (preferably, respectively at least one ethylenic or amine function - possibly terminal-); b- elimination of the precursor;
- H 2 C ⁇ CC [hcCHH 22 -
- CH CH 2 q> 1, eg q 1 and with a second precursor corresponding to:
- SiI-X can be carried out as described in Polymer 44 (2003) 6449-6455 Telechelic polydimethylsiloxane with terminal acetylenic groups prepared by phase transfer catalysis.
- B comprises at least one saccharide with: -> L 3 comprising at least one amino group (for example terminal) having reacted with the anomeric carbon of B, -> and / or L 3 resulting from a precursor comprising at least one halo group (for example bromo) having reacted with OH of SiI; 2. according to a second possibility, B comprises at least one residue (for example saccharide) functionalized by at least one functionalization group belonging to the group comprising carboxylic functionalization groups, carboxylates, anhydrides, thiols, isocyanates and epoxides, with:
- B comprises at least one residue (for example POS) functionalized by at least one functionalization group belonging to the group comprising hydrogen and the units carrying at least one ethylenic unsaturation, with L 3 comprising at least one at least one group (for example terminal) bearing at least one ethylenic unsaturation and / or at least one hydrogen, having reacted with the corresponding functionalization group (s) of B; 4.
- the first three possibilities are combined.
- this B-X synthon can be characterized in that this polyol is a polymer comprising, for example, at least two, preferably at least 3, and more preferably still at least 10 monomer units.
- the preparation of the BX synthon can advantageously comprise the following essential substeps: a- reaction of the anomeric carbon and / or of the functionalization group (s) of B with an excess of at least one precursor of the L 3 bond carrier of a reactive end (preferably at least one amino function - optionally terminal - and / or at least one halo group) capable of reacting with B; b- elimination of the precursor.
- L 3 corresponds to -NH- (CH 2 ) q> 1, with a precursor corresponding to:
- the precursor of the link L 3 could be in particular: acrylonitrile, propargyl alcohol or triethylene glycol monopropargyl.
- B comprises a POS
- the preparation of B-X can be carried out as described in Polymer 44 (2003) 6449-6455 Telechelic potydimethylsiloxane with terminal acetylenic groups prepared by phase transfer catalysis.
- Siil may comprise at least one residue functionalized by at least one functionalization group belonging to the group comprising carboxylic, carboxylate, anhydride, thiol, isocyanate and epoxide functionalization groups with:
- L 2 comprising at least one amino group (for example terminal) having reacted with the group (s) of functionalization SiI, ⁇ and / or L 2 from a precursor comprising at least one halo group (for example bromo) having reacted with the functionalization group (s) of SiI;
- SiI comprises at least one residue (for example POS) functionalized by at least one functionalization group belonging to the group comprising hydrogen and the units carrying at least one ethylenic unsaturation, with L 2 comprising at least one at least one group (for example terminal) bearing at least one ethylenic unsaturation and / or at least one hydrogen, which has reacted with the corresponding functionalization group (s) of SiI;
- residue for example POS
- L 2 comprising at least one at least one group (for example terminal) bearing at least one ethylenic unsaturation and / or at least one hydrogen
- this SiI-Y synthon can be characterized in that Po is a polymer comprising, for example, at least two, preferably at least 3, and more preferably still at least 10 monomer units.
- the preparation of the SiI-Y synthon may advantageously comprise the following essential sub-steps: a reaction of a Siil hydrogen and / or another (or other) Siil functionalization group (s) with an excess of at least one L 2 reactive bond-bearing precursor (preferably, respectively at least one ethylenic or amino-optionally terminal function and / or at least one hydroxyl function and / or at least one halogeno group) capable of reacting with SiI; b- elimination of the precursor;
- the precursor of the link L 2 could be in particular: H 2 N (CH 2 CH 2 O) 3 (CH 2 ) N 3 , H 2 NCH (COOH) (CH 2 ) 2 N 3 or HO (CH 2 ) 6 N 3 .
- H 2 N (CH 2 CH 2 O) 3 (CH 2 ) N 3 H 2 NCH (COOH) (CH 2 ) 2 N 3 or HO (CH 2 ) 6 N 3 .
- B comprises at least one saccharide with:
- B comprises at least one residue (for example POS) functionalized by at least one functionalization group belonging to the group comprising the functional groups carboxylic, carboxylates, anhydrides, thiols, isocyanates and epoxides, with:
- -> and / or L4 is derived from the precursor NaN 3 reacted with the group (s) of functionalization of B epoxide type; -> and / or L4 comprising at least one halogeno group (for example bromo) reacted with the group (s) functionalization of B;
- B comprises at least one residue (for example POS) functionalized by at least one functionalization group belonging to the group comprising hydrogen and the units carrying at least one ethylenic unsaturation, with L4 comprising at least one group (for example, terminal) bearing at least one ethylenic unsaturation having reacted with the functionalization group (s) of B; 4.
- the first three possibilities are combined.
- this B-Y synthon can be characterized in that
- B is a polymer comprising, for example, at least two, preferably at least 3, and more preferably at least 10 monomer units.
- the preparation of the BY synthon may advantageously comprise the following essential substeps: a-reaction of anomeric hydroxyl (s) and / or of the functionalization group (s) of B with an excess at least one precursor of the link L 4, with or without a reactive end (preferably at least one amine functional group - possibly terminal - and / or at least one halo group) and capable of reacting with B; b- elimination of the precursor.
- B-Y is obtained from a B entity carrying epoxide functionalization groups which is reacted with the precursor
- the precursor of the link L4 could for example be in particular: acrylonitrile, propargyl alcohol or triethylene glycol monopropargyl.
- B comprises a POS
- the preparation of B-X can be carried out as described in Polymer 44 (2003) 6449-6455 Telechelic polydimethylsiloxane with terminal acetylenic groups prepared by phase transfer catalysis.
- the mechanism of cycloaddition [step (iii)] at the heart of the process according to the invention is a 1,3-dipolar cycloaddition mechanism of a SiI-X or BY syntheton with reactive units VII.2 azido and a BY synthon or Siil-X reactive units VIL1 acetylenic or nitrile ("click chemistry") catalyzed copper I, preferably in aqueous medium, hydroorganic or organic.
- This mechanism is particularly attractive because of its simplicity, its non-dangerous nature for operators and the environment, its low cost, among others.
- SiI-XY synthons can be used instead of or in addition to the SiI-X synthons and BY synthons, each comprising at least one reactive unit X and at least one at least one reactive unit Y and mixed synthons B-XY each comprising at least one reactive unit X and at least one unit a reagent Y, so that these SiI-XY and B-XY synthons are able to react together.
- the expression "of the order” means that the values concerned are given with an uncertainty, for example of plus or minus 10%.
- the cycloaddition step (iii) to be carried out in an aqueous, hydroalcoholic or organic medium capable of solubilizing and / or swelling the SiI-X synthon and / or the BY synthon, with the aid of at least one metal catalyst in the ionized form, preferably Cu ++ in the presence of at least one reducing agent of Cu ++ + Cu, in situ, said reducing agent being preferably selected from the group consisting of: ascorbate, quinone , hydroquinone, vitamin K, glutathione, cysteine, Fe 2+, Co 2+, applied electrical potential, the metal group comprising Cu, Al, Be, Co, Cr, Fe, Mg, Mn, Ni, and Zn, and mixtures thereof .
- the metal catalyst in ionized form preferably Cu
- Cu is advantageously in the form of salt (s) (ideally sulphate) more preferably still including at least one activator comprising for example at least one acid salt (s). ) organic (ideally ascorbic acid) and at least one alkali metal (ideally Na).
- salt (s) ideally sulphate
- activator comprising for example at least one acid salt (s).
- organic ideally ascorbic acid
- alkali metal ideally Na
- the CuSO 4 / sodium ascorbate system is for example quite suitable.
- the cycloaddition step (iii) is preferably carried out in a reaction medium whose temperature is between 20 and 100 ° C., preferably between 50 and 100 ° C. 80 0 C, for 0.1 to 20 hours, preferably for 0.5 to 15 hours, and more preferably for 1 to 8 hours.
- the heating of the reaction medium is carried out by any appropriate means. Microwave irradiation may constitute, e.g., an interesting heating modality.
- the reaction medium of the cycloaddition step (iii) is an aqueous, hydroorganic or organic medium preferably comprising at least one solvent chosen from:
- aprotic polar solvents preferably dimethylformamide (DMF), diethylacetamide (DMAc), tetrahydrofuran (THF), acetone, methyl ethyl ketone, butanone,
- polar polar solvents preferably methanol, isopropyl alcohol (IPA), t-butanol (t-BuOH),
- apolar solvents preferably toluene, hexane, xylene,
- step of separation (iv) of the hybrid compound - ⁇ - from the reaction medium it may consist in particular in implementing:
- At least one chromatography preferably at least one chromatography on silica gel, using an eluent containing a mixture of a first polar solvent and at least one second less polar solvent, such as, for example, acetonitrile mixture and water. -> and / or at least one evaporation to dry the product.
- the present invention relates to the Siil-X, SiI-Y, BX, BY 5 SiI-XY and B-XY synthons according to the invention, taken as such and defined above in the context of the invention. of the description of the process according to the invention.
- the present invention also relates to the use of a hybrid compound as described above as such or as a product obtained by the process also defined above, as an ingredient in compositions chosen from the group comprising: -> detergent / surfactant compositions
- compositions also constitute another subject of the invention.
- these compositions may be an emulsion, preferably an oil-in-water emulsion comprising a hybrid compound according to the invention.
- the hybrid compounds according to the invention can in particular be presented in the form of oils. They can also be presented in dispersed or solubilized form in a vector, for example at a concentration of 10 to 90% by weight.
- the vector may advantageously be a solvent for the polymer, for example an optionally volatile silicone compound, for example a linear or cyclic polydimethylorganosiloxane such as cyclopentasiloxane, disiloxane, linear dimethicones, or a trimethylsiloxyphenyl dimeticone, or a mixture.
- the hybrid compounds according to the invention may in particular be used as an emulsifier or co-emulsifier for preparing or stabilizing emulsions. They may for example be used in emulsions of which one phase is a silicone oil. Presented as solutions in a polyorganosiloxane, for example in cyclopentasiloxane, they can be used as an emulsifier for water-in-oil or oil-in-silicone emulsions. They can also be used to compatibilize several compounds within a formulation. They can also be used as an agent for assisting the deposit of another compound, or as triggering the deposit of another compound. They can also be used as dispersing or co-dispersing agents to prepare or stabilize dispersions of particles, for example pigments.
- the hybrid compounds according to the invention have the advantages in these applications of being slightly irritating, partially biodegradable or bioabsorbable, of providing a pleasant touch, and / or of providing an advantageous spreading.
- the hybrid compounds can give the compositions in which they are introduced, in the presence of surfactants, preferred foam properties of the consumer, including compactness and / or brightness appreciated by the consumer, with good temporal stability of the foam.
- hybrid compounds exemplified hereinafter are oligoorganosiloxanes or polyorganosiloxanes, more specifically polyimethylsiloxanes (PDMS) with trimethylsilyl ends (MD 10 M) modified with oligosaccharide groups (see structures A, B, C) according to a "click” mechanism. chemistry ".
- PDMS polyimethylsiloxanes
- MD 10 M trimethylsilyl ends
- the reaction medium is kept under magnetic stirring for 40 hours at room temperature. Originally the solution is heterogeneous and becomes after
- reaction medium is evaporated to dryness and coevaporated with a mixture of MeOH and toluene
- the solid is N-acetylated selectively by adding 300 mL of a MeOH solution and
- the reaction medium is kept under magnetic stirring for 3 days at room temperature.
- the solution is quite viscous and orange in color.
- the evolution of the reaction is monitored by thin layer chromatography (CH3CN / H2O - 7: 3 v / v).
- the solid is then subjected to 7V-acetylation by placing it in 400 ml of a solution of
- Trisiloxane 9 (12 g, 35.7 mmol) is diluted in 60 mL of isopropyl alcohol (IPA) and then equiv. of sodium azide (11.5 g, 178.5 mmol), 40 mL of distilled water and
- reaction medium is stirred at 50 ° C. for 4 hours.
- the reaction is monitored by TLC (9: 1 v / v
- reaction medium is diluted with diethyl ether (20OmL) and extracted successively with a sat. NaHCO 3 solution. (2x 100 mL) and water (100 mL). The organic phase is recovered, dried over Na 2 SO 4 , filtered and then evaporated to dryness to give compound Ij) (13.5 g, quantitative yield) as a pale yellow oil and sufficiently pure to be used for the next reaction. .
- IPA isopropyl alcohol
- the reaction medium is stirred at 50 ° C. for 7 hrs.
- the reaction is monitored by 1 H NMR and stopped when the starting material is almost completely consumed.
- reaction medium is diluted with diethyl ether (30 mL) and extracted with water (10 mL). The organic phase is collected, dried over Na 2 SO 4 , filtered and then evaporated to dryness to give 12 (1.95 g, 89%) as a colorless oil and sufficiently pure to be used for the next reaction. .
- the solution is brought to 50 ° C. in an airtight tube and stirred for 1 hour.
- the reaction is monitored by TLC (CH 3 CN / H 2 O - 7: 3 v / v).
- the medium is then diluted in MeOH (5 mL) and then evaporated to dryness in the presence of silica.
- the solution is brought to 50 ° C. in an IL flask and stirred for 1 hour.
- the reaction is monitored by TLC (CH 3 CN / H 2 O - 7: 3 v / v).
- the medium is then diluted in MeOH (25 mL) and then evaporated to dryness in the presence of silica. The residue is deposited on a column of silica gel. After purification by fast chromatography on silica gel (acetonitrile / water: 8-2 v / v), we find a contamination by copper (II) fractions presenting our compounds 16, 17 and 18, visualized by a bluish color. These fractions are combined and then concentrated and subjected to a column filled with a chelating resin, Dowex M4195, previously treated with a solution of 2M NH4OH and then washed with distilled water until a pH of 7 is reached. The compounds 16, 17 and 18 are recovered by passing water on the column and are perfectly decontaminated as shown by the colorless appearance of the solution and the measurement of the conductivity.
- a chelating resin Dowex M4195
- the solution is brought to 50 ° C. in an airtight tube and stirred for 1 hour.
- the reaction is monitored by TLC (CH 3 CN / H 2 O - 7: 3 v / v).
- the medium is then diluted in MeOH (25 mL) and then evaporated to dryness in the presence of silica. The residue is deposited on a column of silica gel. After purification by rapid chromatography on silica gel (acetonitrile / water: 8-2 v / v), the compounds 19, consisting of a multitude of combinations of condensation products and impossible to determine, are obtained with a mass yield of 81%. % (583 mg) and in the form of a white powder after lyophilization.
- GIc and GaI and Xyl and CH 2 OCH 2 Sl CHOH Si , CH (OH) CH 2 N, CH (OH) CH 2 N, CH 2 N (Ac), ⁇ -1); 4.97-5.09 (m, HI xyl ); 5.32 (m, H1 Glc I ⁇ ); 7.82, 7.93 (s, 1H, H-5 taazole ).
- IR (KBr): 3383 (OH), 2961 (CH), 1644 (C O), 1261 (CO), 1044 and 1090 cm- 1 (Si-O).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Silicon Polymers (AREA)
- Saccharide Compounds (AREA)
- Polyethers (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0651744A FR2900929B1 (fr) | 2006-05-15 | 2006-05-15 | Composes hybrides a base de polyol(s) et a base d'au moins une autre entite moleculaire, polymeres ou non, notamment de type polyorganosiloxane, son procede de preparation et ses apllications |
FR0651745A FR2900931A1 (fr) | 2006-05-15 | 2006-05-15 | Composes hybrides a base de silicones et a base d'au moins une autre entite moleculaire, polymere ou non, notamment de type polyol(s), leur procede de preparation et leurs applications |
PCT/EP2007/054691 WO2007132000A1 (fr) | 2006-05-15 | 2007-05-15 | Composes hybrides a base de silicones et a base d'au moins une autre entite moleculaire, polymere ou non, notamment de type polyol(s), leur procede de preparation et leurs applications |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2024422A1 true EP2024422A1 (fr) | 2009-02-18 |
Family
ID=38324142
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07729143A Withdrawn EP2024422A1 (fr) | 2006-05-15 | 2007-05-15 | Composes hybrides a base de silicones et a base d'au moins une autre entite moleculaire, polymere ou non, notamment de type polyol(s), leur procede de preparation et leurs applications |
EP07729152A Withdrawn EP2024382A2 (fr) | 2006-05-15 | 2007-05-15 | Composés hybrides à base de polyol(s) et à base d'au moins une autre entité moléculaire, polymères ou non, notamment de type polyorganosiloxane, son procédé de préparation et ses applications |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07729152A Withdrawn EP2024382A2 (fr) | 2006-05-15 | 2007-05-15 | Composés hybrides à base de polyol(s) et à base d'au moins une autre entité moléculaire, polymères ou non, notamment de type polyorganosiloxane, son procédé de préparation et ses applications |
Country Status (4)
Country | Link |
---|---|
EP (2) | EP2024422A1 (fr) |
JP (1) | JP2009537484A (fr) |
BR (1) | BRPI0711835A2 (fr) |
WO (2) | WO2007132000A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20061726A1 (it) * | 2006-09-11 | 2008-03-12 | Fidia Farmaceutici | Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry |
FR2923828B1 (fr) * | 2007-11-16 | 2010-02-19 | Rhodia Operations | Composes hybrides a base de polyasaccharides(s) et d'au moins un polyoxyalkylene, leur procede de preparation et leurs applications |
DE102008040886A1 (de) * | 2008-07-31 | 2010-02-04 | Wacker Chemie Ag | Durch Click-Reaktion vernetzbare mehrkomponentige Siliconzusammensetzungen |
US20110077365A1 (en) * | 2008-12-29 | 2011-03-31 | Gilbert Yu | Preparation of organosilicon-containing triazoles |
US8535477B2 (en) | 2009-02-21 | 2013-09-17 | Sofradim Production | Medical devices incorporating functional adhesives |
US8247614B2 (en) * | 2009-06-17 | 2012-08-21 | E I Du Pont De Nemours And Company | Copolycondensation polymerization of fluoropolymers |
CA2804263A1 (fr) | 2010-06-29 | 2012-01-12 | Tyco Healthcare Group Lp | Reacteur alimente par micro-ondes et methode de formation in situ d'implants |
US8865857B2 (en) | 2010-07-01 | 2014-10-21 | Sofradim Production | Medical device with predefined activated cellular integration |
US9775928B2 (en) | 2013-06-18 | 2017-10-03 | Covidien Lp | Adhesive barbed filament |
CN104226283B (zh) * | 2014-08-28 | 2017-03-29 | 华东理工大学 | 聚乙烯醇涂覆型色谱固定相及其制备方法与应用 |
JP2016079242A (ja) * | 2014-10-14 | 2016-05-16 | ナガセケムテックス株式会社 | 自己組織化能を有する化合物、自己組織化パターン形成用材料、及び、自己組織化した薄膜の製造方法 |
CN104403129B (zh) * | 2014-11-07 | 2017-06-13 | 上海交通大学 | 双组份交联剂及其制备方法、用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3168544A (en) * | 1961-08-23 | 1965-02-02 | Union Carbide Corp | Preparation of cyanoalkylsilanes |
US6340670B1 (en) * | 1998-11-24 | 2002-01-22 | American Home Products Corporation | Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
CN1394867A (zh) * | 2001-07-06 | 2003-02-05 | 中国科学院生态环境研究中心 | 可作药物的寡糖和其制备方法及含该寡糖的药物组合物 |
DE10132942A1 (de) * | 2001-07-06 | 2003-01-23 | Degussa | Siloxan-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
US7375234B2 (en) * | 2002-05-30 | 2008-05-20 | The Scripps Research Institute | Copper-catalysed ligation of azides and acetylenes |
FR2867480B1 (fr) * | 2004-03-10 | 2008-08-08 | Rhodia Chimie Sa | Polymere greffe comprenant un squelette polyorganosiloxane et des motifs glycoside |
EP1602663A1 (fr) * | 2004-06-04 | 2005-12-07 | Chiralix B.V. | Glycopeptides et/ou glycoaminoacides liés par une liaison triazole |
-
2007
- 2007-05-15 JP JP2009510443A patent/JP2009537484A/ja active Pending
- 2007-05-15 EP EP07729143A patent/EP2024422A1/fr not_active Withdrawn
- 2007-05-15 WO PCT/EP2007/054691 patent/WO2007132000A1/fr active Application Filing
- 2007-05-15 WO PCT/EP2007/054702 patent/WO2007132005A2/fr active Application Filing
- 2007-05-15 BR BRPI0711835-0A patent/BRPI0711835A2/pt not_active Application Discontinuation
- 2007-05-15 EP EP07729152A patent/EP2024382A2/fr not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO2007132000A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007132000A1 (fr) | 2007-11-22 |
WO2007132005A3 (fr) | 2008-04-24 |
EP2024382A2 (fr) | 2009-02-18 |
BRPI0711835A2 (pt) | 2011-12-13 |
WO2007132005A2 (fr) | 2007-11-22 |
JP2009537484A (ja) | 2009-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2024422A1 (fr) | Composes hybrides a base de silicones et a base d'au moins une autre entite moleculaire, polymere ou non, notamment de type polyol(s), leur procede de preparation et leurs applications | |
US20090253609A1 (en) | Hybrid compounds based on silicones, and at least one other molecular entity, polymer or otherwise, especially of the polyol type, method for the preparation thereof, and applications of the same | |
WO2009063082A1 (fr) | Composés hybrides à base de polysaccharide(s) et d'au moins un polyoxyalkylène, leur procédé de préparation et leurs applications. | |
EP1453888B1 (fr) | Organopolycarbosiloxanes fonctionnels a residus saccharidiques et leur procede de preparation | |
EP1446440B1 (fr) | Organopolysiloxanes fonctionnels a residus saccharidiques et leur procede de preparation | |
EP1742988B1 (fr) | Polymere greffe comprenant un squelette polyorganosiloxane et des motifs glycoside | |
WO2009125126A2 (fr) | Polysiloxanes fonctionnalisés, leur procédé de préparation et leurs utilisations | |
CN114667299B (zh) | 硅聚糖及其制备方法 | |
JP2004231608A (ja) | 化粧料 | |
EP0975315A1 (fr) | Composition cosmetique a base de polyurethannes associatifs et de silicones quaternaires | |
JP4764547B2 (ja) | 化粧料 | |
FR2873123A1 (fr) | Nouveaux glycopolymeres, leurs utilisations, et monomeres utiles pour leur preparation | |
FR2900931A1 (fr) | Composes hybrides a base de silicones et a base d'au moins une autre entite moleculaire, polymere ou non, notamment de type polyol(s), leur procede de preparation et leurs applications | |
FR2900929A1 (fr) | Composes hybrides a base de polyol(s) et a base d'au moins une autre entite moleculaire, polymeres ou non, notamment de type polyorganosiloxane, son procede de preparation et ses apllications | |
FR2750322A1 (fr) | Dispersions concentrees comprenant un polysaccharide cationique hydrosoluble, leur procede de preparation et leur utilisation dans des compositions cosmetiques | |
JP2004250699A (ja) | 洗浄剤組成物 | |
EP4061855A1 (fr) | Procédé de préparation d'un glycane de silicium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20081112 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: FORT, SEBASTIEN Inventor name: HAMAIDE, THIERRY Inventor name: COTTAZ, SYLVAIN Inventor name: DRIGUEZ, HUGUES Inventor name: HALILA, SAMI Inventor name: FLEURY, ETIENNE |
|
17Q | First examination report despatched |
Effective date: 20090403 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20110909 |